Table 2.

Expenditures in sevelamer and calcium groups (dosed cohort with 90-day follow-up rule^a)

	Raw PPPM Costs ($)			Inflation-Adjusted PPPM Costs ($)
	Calcium(n = 961)	Sevelamer(n = 934)	Pb	Calcium(n = 961)	Sevelamer(n = 934)	Pb
Total			0.06			0.06
Mean ± SDc	5724 ± 2863	5529 ± 2663		5435 ± 2768	5236 ± 2550
Median	5179	4905		4933	4653
Min-Max	809–101,446	1078–42,117		809–100,169	1071–42,286
Inpatient			0.05			0.05
Mean ± SDc	1729 ± 2270	1544 ± 2027		1644 ± 2189	1461 ± 1937
Median	1196	965		1144	909
Min-Max	0–101,446	0–39,855		0–100,169	0–40,015
Outpatient			0.14			0.15
Mean ± SDc	3711 ± 1115	3730 ± 1052		3521 ± 1064	3535 ± 1000
Median	3364	3441		3234	3297
Min-Max	0–12,095	1078–16,284		0–11,697	1071–15,972
SNF			0.19			0.19
Mean ± SDc	110 ± 405	80 ± 307		105 ± 391	76 ± 296
Median	0	0		0	0
Min-Max	0–7152	0–6,173		0–6966	0–6166
Other			0.07			0.06
Mean ± SDc	175 ± 319	174 ± 334		166 ± 306	164 ± 317
Median	37	25		36	24
Min-Max	0–4707	0–3423		0–4556	0–3322

Estimated costs of phosphate binders are not included in this table.

Max, maximum value; Min, minimum value; SNF, skilled nursing facility.

^aEarly-termination patients followed an additional 90 d after early termination.

^bWilcoxon rank sum test.

^cWeighted mean with follow-up time as the weight.